Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | HPD | P32754 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | KCNMA1 | Q12791 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL998548 | 0.88 | SMN1; SMN2 (0.43) | HPDCYP3A4POLBLMNASMN1; SMN2 | |
| SCHEMBL997023 | 0.86 | HPD (0.36) | HPDALDH1A1POLBMAPTMEN1 | |
| SCHEMBL9441394 | 0.83 | HPD (0.36) | HPDCYP3A4ALDH1A1MAPTHTT | |
| SCHEMBL997179 | 0.83 | HPD (0.40) | HPDALDH1A1MAPTHTTMEN1 | |
| SCHEMBL14155650 | 0.77 | TSHR (0.44) | TSHRHPDCYP3A4ALDH1A1POLB | |
| SCHEMBL9871935 | 0.73 | SMN1; SMN2 (0.48) | HPDCYP3A4POLBLMNASMN1; SMN2 | |
| SCHEMBL13327441 | 0.72 | HPD (0.67) | TSHRHPDCYP3A4ALDH1A1MAPT | |
| SCHEMBL9711467 | 0.70 | HPD (0.43) | TSHRHPDCYP3A4ALDH1A1POLB | |
| SCHEMBL9739114 | 0.69 | HPD (0.38) | HPDALDH1A1POLBMAPTMEN1 | |
| SCHEMBL8713774 | 0.68 | SMN1; SMN2 (0.46) | HPDCYP3A4POLBLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0614606-B1 | Herbicidal compositions | BASF AG (DE) | 2003-09-10 | — | — | EP | claimed |
| US-5990046-A | AGGREGATE AMOUNT OF A TRIKETONE OR DIONE HERBICIDE SUCH AS SULCOTRIONE, AND DIMETHENAMID IN A WEIGHT RATIO BETWEEN 1:2 AND 1:10; CONTROLLING WEEDS IN THE PRESENCE OF A CROP; IMPROVED HERBICIDAL ACTIVITY | SANDOZ LTD. (CH) | 1999-11-23 | — | — | US | claimed |
| US-20140234225-A1 | METHOD OF TREATMENT USING NANOPARTICULATE COMPOSITIONS HAVING LYSOZYME AS A SURFACE STABILIZER | ALKERMES PHARMA IRELAND LIMITED (IE) | 2014-08-21 | — | — | US | disclosed |
| US-8652464-B2 | Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizer | ALKERMES PHARMA IRELAND LIMITED (IE) | 2014-02-18 | — | — | US | disclosed |
| US-20130224123-A1 | NANOPARTICULATE COMPOSITIONS HAVING LYSOZYME AS A SURFACE STABILIZER | ALKERMES PHARMA IRELAND LIMITED (IE) | 2013-08-29 | — | — | US | disclosed |
| US-8323641-B2 | Nanoparticulate compositions having lysozyme as a surface stabilizer | ALKERMES PHARMA IRELAND LIMITED (IE) | 2012-12-04 | — | — | US | disclosed |
| EP-2272342-B1 | Herbicidal compositions | BASF SE (DE) | 2012-06-27 | — | — | EP | disclosed |
| EP-2272342-A2 | Herbicidal compositions | BASF SE (DE) | 2011-01-12 | — | — | EP | disclosed |
| EP-2272341-A2 | Herbizide Zusammensetzungen | BASF SE (DE) | 2011-01-12 | — | — | EP | disclosed |
| US-7850995-B2 | Bioadhesive nanoparticulate compositions having cationic surface stabilizers | ELAN PHARMA INTERNATIONAL, LTD. (IE) | 2010-12-14 | — | — | US | disclosed |
| EP-1810570-B1 | Herbicidal compositions | BASF SE (DE) | 2009-07-15 | — | — | EP | disclosed |
| US-5877118-A | CARBOXYLIC ACID-SUBSTITUTED AROMATIC SEMICARBAZONES | BASF AKTIENGESELLSCHAFT (DE) | 1999-03-02 | — | — | US | disclosed |
| US-5721191-A | APPLYING CONCURRENTLY | SANDOZ LTD. (CH) | 1998-02-24 | — | — | US | disclosed |
| US-5686387-A | HERBICIDE POTENTIATORS | BASF AKTIENGESELLSCHAFT (DE) | 1997-11-11 | — | — | US | disclosed |
| US-5683960-A | HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1997-11-04 | — | — | US | disclosed |
| US-5681793-A | HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1997-10-28 | — | — | US | disclosed |
| US-5665673-A | SEMICARBAZONES | BASF AKTIENGESELLSCHAFT (DE) | 1997-09-09 | — | — | US | disclosed |
| US-5665674-A | SEMICARBAZONES | SANDOZ LTD. (CH) | 1997-09-09 | — | — | US | disclosed |
| EP-0646315-A1 | Novel compositions containing an auxin transport inhibitor and another herbicide | SANDOZ LTD. (CH) | 1995-04-05 | — | — | EP | disclosed |
| EP-0614606-A2 | Herbicidal compositions | SANDOZ LTD. (CH) | 1994-09-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140234225-A1 | METHOD OF TREATMENT USING NANOPARTICULATE COMPOSITIONS HAVING LYSOZYME AS A SURFACE STABILIZER | LPO, LCT, LIPA | TSHR 939/4885HPD 1827/4885CYP3A4 1290/4885 |
| US-20130224123-A1 | NANOPARTICULATE COMPOSITIONS HAVING LYSOZYME AS A SURFACE STABILIZER | LPO, LCT, CTSA | TSHR 1167/4885HPD 1972/4885CYP3A4 1286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.